on Tanvex BioPharma
Tanvex CDMO to Showcase Expertise at World ADC Conference
Tanvex CDMO will participate in the 15th Annual World ADC Conference in San Diego from November 4-7, 2024. The company invites attendees to Booth #416 to discuss collaboration opportunities and trends in bispecific process development and cell-based assays. Tanvex CDMO, a Contract Development and Manufacturing Organization, specializes in biologic drug development and GMP manufacturing. Its experts assist partners through investigational stages to regulatory approval.
Recently, Tanvex CDMO has shared industry knowledge through publications such as optimizing ADCC bioassays and risk assessment for product comparability. The company encourages conference attendees to network and discuss innovations in biopharmaceutical development.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Tanvex BioPharma news